Publications 2022

Fontaine MAC, Jin H, Gagliardi M, Rousch M, Wijnands E, Stoll M, Li X, Schurgers L, Reutelingsperger C, Schalkwijk C, van den Akker NMS, Molin DGM, Gullestad L, Eritsland J, Hoffman P, Skjelland M, Andersen GØ, Aukrust P, Karel J, Smirnov E, Halvorsen B, Temmerman L, Biessen EAL (2022)
Blood Milieu in Acute Myocardial Infarction Reprograms Human Macrophages for Trauma Repair
Adv Sci (Weinh), 10 (5), e2203053
DOI 10.1002/advs.202203053, PubMed 36526599

Publications 2021

Tøllefsen IM, Shetelig C, Seljeflot I, Eritsland J, Hoffmann P, Andersen GØ (2021)
High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
Open Heart, 8 (2)
DOI 10.1136/openhrt-2021-001869, PubMed 34933964

Publications 2020

Langseth MS, Andersen GØ, Husebye T, Arnesen H, Zucknick M, Solheim S, Eritsland J, Seljeflot I, Opstad TB, Helseth R (2020)
Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure
PLoS One, 15 (10), e0241333
DOI 10.1371/journal.pone.0241333, PubMed 33119664

Langseth MS, Helseth R, Ritschel V, Hansen CH, Andersen GØ, Eritsland J, Halvorsen S, Fagerland MW, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2020)
Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction
Sci Rep, 10 (1), 5007
DOI 10.1038/s41598-020-61971-7, PubMed 32193509

Nakstad ER, Stær-Jensen H, Wimmer H, Henriksen J, Alteheld LH, Reichenbach A, Drægni T, Šaltytė-Benth J, Wilson JA, Etholm L, Øijordsbakken M, Eritsland J, Seljeflot I, Jacobsen D, Andersen GØ, Lundqvist C, Sunde K (2020)
Late awakening, prognostic factors and long-term outcome in out-of-hospital cardiac arrest - results of the prospective Norwegian Cardio-Respiratory Arrest Study (NORCAST)
Resuscitation, 149, 170-179
DOI 10.1016/j.resuscitation.2019.12.031, PubMed 31926258

Sandven I, Eritsland J, Abdelnoor M (2020)
Remote Ischemic Conditioning in Patients with Acute Coronary Syndromes: A Systematic Review with Meta-Analysis and Trial Sequential Analysis
Clin Epidemiol, 12, 595-605
DOI 10.2147/CLEP.S249785, PubMed 32606985

Publications 2019

Eritsland J, Andersen GO (2019)
MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI (vol 13, e0206723, 2018)
PLoS One, 14 (3), e0213636
DOI 10.1371/journal.pone.0213636

Helseth R, Knudsen EC, Eritsland J, Opstad TB, Arnesen H, Andersen GØ, Seljeflot I (2019)
Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study
BMC Cardiovasc Disord, 19 (1), 221
DOI 10.1186/s12872-019-1205-1, PubMed 31615411

Helseth R, Shetelig C, Andersen GØ, Langseth MS, Limalanathan S, Opstad TB, Arnesen H, Hoffmann P, Eritsland J, Seljeflot I (2019)
Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI
Mediators Inflamm, 2019, 7816491
DOI 10.1155/2019/7816491, PubMed 31772506

Knudsen EC, Seljeflot I, Aksnes TA, Eritsland J, Arnesen H, Andersen GØ (2019)
IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome
PLoS One, 14 (4), e0215640
DOI 10.1371/journal.pone.0215640, PubMed 31002684

Kvakkestad KM, Gran JM, Eritsland J, Holst Hansen C, Fossum E, Andersen GØ, Halvorsen S (2019)
Long-Term Survival after Invasive or Conservative Strategy in Elderly Patients with non-ST-Elevation Myocardial Infarction: A Prospective Cohort Study
Cardiology, 144 (3-4), 79-89
DOI 10.1159/000503442, PubMed 31689705

Lunde NN, Gregersen I, Ueland T, Shetelig C, Holm S, Kong XY, Michelsen AE, Otterdal K, Yndestad A, Broch K, Gullestad L, Nyman TA, Bendz B, Eritsland J, Hoffmann P, Skagen K, Gonçalves I, Nilsson J, Grenegård M, Poreba M, Drag M, Seljeflot I, Sporsheim B, Espevik T, Skjelland M et al. (2019)
Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages
Atherosclerosis, 296, 74-82
DOI 10.1016/j.atherosclerosis.2019.12.008, PubMed 31870625

Publications 2018

Bethke A, Shanmuganathan L, Andersen GØ, Eritsland J, Swanson D, Kløw NE, Hoffmann P (2018)
Microvascular perfusion in infarcted and remote myocardium after successful primary PCI: angiographic and CMR findings
Eur Radiol, 29 (2), 941-950
DOI 10.1007/s00330-018-5588-7, PubMed 29980929

Bethke A, Shanmuganathan L, Shetelig C, Swanson D, Andersen GØ, Eritsland J, Kløw NE, Hoffmann P (2018)
MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI
PLoS One, 13 (11), e0206723
DOI 10.1371/journal.pone.0206723, PubMed 30412607

Hansen CH, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Seljeflot I (2018)
Markers of Thrombin Generation Are Associated With Long-Term Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction
Clin Appl Thromb Hemost, 24 (7), 1088-1094
DOI 10.1177/1076029618764847, PubMed 29695176

Orrem HL, Shetelig C, Ueland T, Limalanathan S, Nilsson PH, Husebye T, Aukrust P, Seljeflot I, Hoffmann P, Eritsland J, Mollnes TE, Andersen GØ, Yndestad A (2018)
Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction
Int J Cardiol, 268, 187-192
DOI 10.1016/j.ijcard.2018.05.032, PubMed 29853279

Shetelig C, Limalanathan S, Hoffmann P, Seljeflot I, Gran JM, Eritsland J, Andersen GØ (2018)
Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI
J Am Coll Cardiol, 72 (2), 187-198
DOI 10.1016/j.jacc.2018.04.053, PubMed 29976293

Staer-Jensen H, Sunde K, Nakstad ER, Eritsland J, Andersen GØ (2018)
Comparison of three haemodynamic monitoring methods in comatose post cardiac arrest patients
Scand Cardiovasc J, 52 (3), 141-148
DOI 10.1080/14017431.2018.1450992, PubMed 29544369

Publications 2017

Husebye T, Eritsland J, Bjørnerheim R, Andersen GØ (2017)
Systolic mitral annulus velocity is a sensitive index for changes in left ventricular systolic function during inotropic therapy in patients with acute heart failure
Eur Heart J Acute Cardiovasc Care, 7 (4), 321-329
DOI 10.1177/2048872616687114, PubMed 28045338

Kvakkestad KM, Wang Fagerland M, Eritsland J, Halvorsen S (2017)
Gender differences in all-cause, cardiovascular and cancer mortality during long-term follow-up after acute myocardial infarction; a prospective cohort study
BMC Cardiovasc Disord, 17 (1), 75
DOI 10.1186/s12872-017-0508-3, PubMed 28288586

Ritschel V, Shetelig C, Seljeflot I, Limalanathan S, Hoffmann P, Halvorsen S, Arnesen H, Eritsland J, Andersen GØ (2017)
Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
Sci Rep, 7 (1), 11945
DOI 10.1038/s41598-017-12372-w, PubMed 28931920

Shetelig C, Limalanathan S, Eritsland J, Hoffmann P, Seljeflot I, Gran JM, Aukrust P, Ueland T, Andersen GØ (2017)
Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
PLoS One, 12 (3), e0173034
DOI 10.1371/journal.pone.0173034, PubMed 28253327

Publications 2016

Chiva-Blanch G, Bratseth V, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Badimon L, Seljeflot I (2016)
Monocyte-derived circulating microparticles (CD14⁺, CD14⁺/CD11b⁺ and CD14⁺/CD142⁺) are related to long-term prognosis for cardiovascular mortality in STEMI patients
Int J Cardiol, 227, 876-881
DOI 10.1016/j.ijcard.2016.11.302, PubMed 27915085

Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Eritsland J, Fagerland MW, Andersen GØ (2016)
Circulating Levels of IL-6 Receptor and gp130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction
J Am Heart Assoc, 5 (6)
DOI 10.1161/JAHA.115.003014, PubMed 27412895

Publications 2015

Hansen CH, Ritschel V, Halvorsen S, Andersen GØ, Bjørnerheim R, Eritsland J, Arnesen H, Seljeflot I (2015)
Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
Thromb J, 13, 31
DOI 10.1186/s12959-015-0061-1, PubMed 26396552

Kvakkestad KM, Abdelnoor M, Claussen PA, Eritsland J, Fossum E, Halvorsen S (2015)
Long-term survival in octogenarians and older patients with ST-elevation myocardial infarction in the era of primary angioplasty: A prospective cohort study
Eur Heart J Acute Cardiovasc Care, 5 (3), 243-52
DOI 10.1177/2048872615574706, PubMed 25753053

Limalanathan S, Eritsland J, Kløw NE, Abdelnoor M, Hoffmann P, Andersen GØ (2015)
Influence of ischemic postconditioning on myocardial dysfunction measured by speckle tracking echocardiography in patients with ST-elevation myocardial infarction
Int J Cardiol, 187, 459-61
DOI 10.1016/j.ijcard.2015.03.192, PubMed 25846653

Stær-Jensen H, Nakstad ER, Fossum E, Mangschau A, Eritsland J, Drægni T, Jacobsen D, Sunde K, Andersen GØ (2015)
Post-Resuscitation ECG for Selection of Patients for Immediate Coronary Angiography in Out-of-Hospital Cardiac Arrest
Circ Cardiovasc Interv, 8 (10)
DOI 10.1161/CIRCINTERVENTIONS.115.002784, PubMed 26453688

Publications 2014

Abdelnoor M, Sandven I, Limalanathan S, Eritsland J (2014)
Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials
Vasc Health Risk Manag, 10, 477-91
DOI 10.2147/VHRM.S67154, PubMed 25143742

Claussen PA, Abdelnoor M, Kvakkestad KM, Eritsland J, Halvorsen S (2014)
Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction
Vasc Health Risk Manag, 10, 683-9
DOI 10.2147/VHRM.S72764, PubMed 25525366

Husebye T, Eritsland J, Arnesen H, Bjørnerheim R, Mangschau A, Seljeflot I, Andersen GØ (2014)
Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure
PLoS One, 9 (11), e112359
DOI 10.1371/journal.pone.0112359, PubMed 25390695

Limalanathan S, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P, Eritsland J (2014)
Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial
J Am Heart Assoc, 3 (2), e000679
DOI 10.1161/JAHA.113.000679, PubMed 24760962

Stær-Jensen H, Sunde K, Olasveengen TM, Jacobsen D, Drægni T, Nakstad ER, Eritsland J, Andersen GØ (2014)
Bradycardia during therapeutic hypothermia is associated with good neurologic outcome in comatose survivors of out-of-hospital cardiac arrest
Crit Care Med, 42 (11), 2401-8
DOI 10.1097/CCM.0000000000000515, PubMed 25072762

Publications 2013

Husebye T, Eritsland J, Müller C, Sandvik L, Arnesen H, Seljeflot I, Mangschau A, Bjørnerheim R, Andersen GØ (2013)
Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study
Eur J Heart Fail, 15 (5), 565-72
DOI 10.1093/eurjhf/hfs215, PubMed 23288914

Limalanathan S, Eritsland J (2013)
What is the optimal cardioprotective treatment of reperfusion injury?
Cardiology, 125 (2), 131-2
DOI 10.1159/000351091, PubMed 23711997

Limalanathan S, Eritsland J, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P (2013)
Myocardial salvage is reduced in primary PCI-treated STEMI patients with microvascular obstruction, demonstrated by early and late CMR
PLoS One, 8 (8), e71780
DOI 10.1371/journal.pone.0071780, PubMed 23977143

Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Weiss T, Eritsland J, Andersen GØ (2013)
IL-6 signalling in patients with acute ST-elevation myocardial infarction
Results Immunol, 4, 8-13
DOI 10.1016/j.rinim.2013.11.002, PubMed 24707455

Publications 2012

Abdelnoor M, Eritsland J, Brunborg C, Halvorsen S (2012)
Ethnicity and acute myocardial infarction: risk profile at presentation, access to hospital management, and outcome in Norway
Vasc Health Risk Manag, 8, 505-15
DOI 10.2147/VHRM.S33627, PubMed 22956878

Kamal Z, Andersen GØ, Smith G, Stornes F, Stensæth KH, Eritsland J (2012)
[A woman with a chronic cough and dyspnoea]
Tidsskr Nor Laegeforen, 132 (12-13), 1466-9
DOI 10.4045/tidsskr.11.0615, PubMed 22766821

Publications 2011

Bendz B, Endresen K, Eritsland J, Arnesen H (2011)
[Don't withdraw all blood platelet inhibitors]
Tidsskr Nor Laegeforen, 131 (8), 800; author reply 800
DOI 10.4045/tidsskr.11.0278, PubMed 21556070

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GO (2011)
Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study
BMC Endocr Disord, 11, 14
DOI 10.1186/1472-6823-11-14, PubMed 21801387

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ (2011)
Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction
J Thromb Haemost, 9 (8), 1468-74
DOI 10.1111/j.1538-7836.2011.04377.x, PubMed 21624046

Weiss TW, Eritsland J (2011)
Anterior or inferior?
Wien Klin Wochenschr, 123 (9-10), 268
DOI 10.1007/s00508-010-1521-z, PubMed 21253773

Weiss TW, Eritsland J (2011)
ECG in acute myocardial infarction - inferior not anterior but left and right Reply
Wien. Klin. Wochen., 123 (15-16), 520

Publications 2010

Eritsland J, Fossum E (2010)
Chronic occlusion of the left main coronary artery: importance of collaterals
Cardiology, 117 (2), 128-30
DOI 10.1159/000321264, PubMed 20975264

Knudsen EC, Seljeflot I, Michael A, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ (2010)
Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study
Cardiovasc Diabetol, 9, 47
DOI 10.1186/1475-2840-9-47, PubMed 20809989

Limalanathan S, Andersen GØ, Hoffmann P, Kløw NE, Abdelnoor M, Eritsland J (2010)
Rationale and design of the POSTEMI (postconditioning in ST-elevation myocardial infarction) study
Cardiology, 116 (2), 103-9
DOI 10.1159/000316965, PubMed 20588018

Tjugen TB, Eritsland J, Mangschau A, Andersen GØ (2010)
[A man in his sixties with myocardial infarction, stent thrombosis and haemorrhage]
Tidsskr Nor Laegeforen, 130 (6), 613-5
DOI 10.4045/tidsskr.09.0320, PubMed 20349007

Publications 2009

Halvorsen S, Eritsland J, Abdelnoor M, Holst Hansen C, Risøe C, Midtbø K, Bjørnerheim R, Mangschau A (2009)
Gender differences in management and outcome of acute myocardial infarctions treated in 2006-2007
Cardiology, 114 (2), 83-8
DOI 10.1159/000216582, PubMed 19420934

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, Andersen GO (2009)
Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients
Cardiovasc Diabetol, 8, 6
DOI 10.1186/1475-2840-8-6, PubMed 19183453

Weiss TW, Stensaeth KH, Eritsland J (2009)
Myocarditis in a juvenile patient with influenza A virus infection
Eur Heart J, 31 (3), 277
DOI 10.1093/eurheartj/ehp566, PubMed 20007610

Publications 2008

Hofstad B, Nesbakken A, Eritsland J, Brørs O, Sandset PM (2008)
[Should platelet inhibitors be discontinued before gastrointestinal endoscopy?]
Tidsskr Nor Laegeforen, 128 (21), 2440-2
PubMed 19096466

Publications 2006

Andersen GØ, Eritsland J, Aasheim A, Neuburger J, Knudsen EC, Mangschau A (2006)
[Impaired glucose tolerance in patients with acute myocardial infarction]
Tidsskr Nor Laegeforen, 126 (17), 2264-7
PubMed 16967066

Publications 2005

Andersen GØ, Eritsland J, Bjørnerheim R, Kløw NE, Jonassen A, Mangschau A (2005)
[Cardiogenic shock-- new therapeutic strategies]
Tidsskr Nor Laegeforen, 125 (10), 1318-21
PubMed 15909001

Eritsland J (2005)
[Is there a difference between low-molecular-weight heparins?]
Tidsskr Nor Laegeforen, 125 (20), 2802-3
PubMed 16244685

Eritsland J, Kløw NE, Westheim A, Bendz B, Mangschau A (2005)
[Primary angioplasty in acute ST elevation myocardial infarction in the elderly]
Tidsskr Nor Laegeforen, 125 (21), 2922-4
PubMed 16276371

Opdahl H, Eritsland J, Søvik E (2005)
Acute myocardial infarction and thyrotoxic storm--a difficult and dangerous combination
Acta Anaesthesiol Scand, 49 (5), 707-11
DOI 10.1111/j.1399-6576.2005.00676.x, PubMed 15836689

Publications 2004

Bendz B, Eritsland J, Nakstad AR, Brekke M, Kløw NE, Steen PA, Mangschau A (2004)
Long-term prognosis after out-of-hospital cardiac arrest and primary percutaneous coronary intervention
Resuscitation, 63 (1), 49-53
DOI 10.1016/j.resuscitation.2004.04.006, PubMed 15451586

Eritsland J, Arnesen H (2004)
[Secondary prophylaxis after myocardial infarction, bypass surgery and percutaneous coronary intervention]
Tidsskr Nor Laegeforen, 124 (7), 946-9
PubMed 15060643

Pettersen AA, Müller C, Bendz B, Halvorsen S, Eritsland J, Brekke M, Mangschau A (2004)
[Reduction of myocardial infarction size after primary percutaneous coronary intervention]
Tidsskr Nor Laegeforen, 124 (10), 1387-9
PubMed 15195177

Publications 2003

Eid HM, Eritsland J, Larsen J, Arnesen H, Seljeflot I (2003)
Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin
Atherosclerosis, 166 (2), 279-84
DOI 10.1016/s0021-9150(02)00206-x, PubMed 12535740

Fossum E, Ata B, Eritsland J, Kløw NE, Mangschau A (2003)
[Aortic dissection--a differential diagnosis in patients with chest pain and ECG changes]
Tidsskr Nor Laegeforen, 123 (17), 2430-2
PubMed 14562777

Publications 2002

Halvorsen S, Müller C, Bendz B, Eritsland J, Brekke M, Mangschau A (2002)
[Left ventricular function and infarction size after primary angioplasty for acute myocardial infarction]
Tidsskr Nor Laegeforen, 122 (24), 2350-4
PubMed 12448247

Publications 2001

Halvorsen S, Müller C, Bendz B, Eritsland J, Brekke M, Mangschau A (2001)
Left ventricular function and infarct size 20 months after primary angioplasty for acute myocardial infarction
Scand Cardiovasc J, 35 (6), 379-84
DOI 10.1080/14017430152754862, PubMed 11837517

Kløw NE, Bendz B, Eritsland J, Hoffman P, Stavnes S, Stensaeth KH, Søvik E, Brekke M, Mangschau A (2001)
[Angiographic results of primary angioplasty in acute myocardial infarction]
Tidsskr Nor Laegeforen, 121 (7), 780-3
PubMed 11301697

Mangschau A, Bendz B, Eritsland J, Stavnes S, Müller C, Brekke M, Kløw NE (2001)
[Hundred patients with acute myocardial infarction treated with primary angioplasty]
Tidsskr Nor Laegeforen, 121 (7), 775-9
PubMed 11301696

Mangschau A, Eritsland J, Stavnes S, Sevre K, Stenseth KH, Kløw NE, Müller C, Sandvik L, Bendz B (2001)
[Long-term follow-up of 100 patients with acute myocardial infarction treated with angioplasty]
Tidsskr Nor Laegeforen, 121 (25), 2930-2
PubMed 11715775

Refsum HE, Eritsland J, Müller OK (2001)
Excessive exercise ventilation in moderate left heart dysfunction. Influence of postural changes in central haemodynamics and blood gases
Clin Physiol, 21 (2), 141-9
DOI 10.1046/j.1365-2281.2001.00317.x, PubMed 11318821

Solheim S, Seljeflot I, Arnesen H, Eritsland J, Eikvar L (2001)
Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks
Atherosclerosis, 157 (2), 411-5
DOI 10.1016/s0021-9150(00)00725-5, PubMed 11472741

Publications 2000

Eritsland J (2000)
Safety considerations of polyunsaturated fatty acids
Am J Clin Nutr, 71 (1 Suppl), 197S-201S
DOI 10.1093/ajcn/71.1.197S, PubMed 10617971

Publications 1999

Bendz B, Mangschau A, Eritsland J, Müller C, Brekke M (1999)
[Angioplasty in heart arrest]
Tidsskr Nor Laegeforen, 119 (23), 3410-3
PubMed 10553336

Publications 1998

Eritsland J (1998)
Influence of dietary n-3 fatty acid supplementation on coronary artery bypass graft patency
FOURTH INTERNATIONAL CONGRESS ON ESSENTIAL FATTY ACIDS AND EICOSANOIDS, 243-247

Mangschau A, Bendz B, Rostrup M, Eritsland J, Müller C, Kjellevand TO, Brekke M (1998)
[Angioplasty in acute myocardial infarction]
Tidsskr Nor Laegeforen, 118 (5), 687-91
PubMed 9528363

Publications 1996

Eritsland J (1996)
Graft occlusion after coronary artery bypass surgery, with special emphasis on the effect of n-3 fatty acids
Department of Cardiology, Ullevål Hospital, University ofOslo, Oslo, 1 b. (flere pag.)
BIBSYS 960606017, ISBN 82-993856-0-1

Eritsland J, Arnesen H, Grønseth K, Fjeld NB, Abdelnoor M (1996)
Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency
Am J Cardiol, 77 (1), 31-6
DOI 10.1016/s0002-9149(97)89130-8, PubMed 8540453

Steine S, Laerum E, Eritsland J, Arnesen H (1996)
Predictors of enhanced well-being after coronary artery bypass surgery
J Intern Med, 239 (1), 69-73
DOI 10.1046/j.1365-2796.1996.425768000.x, PubMed 8551203

Publications 1995

Arnesen H, Sandset PM, Eritsland J (1995)
[Fat-soluble vitamins in clinical practice]
Tidsskr Nor Laegeforen, 115 (7), 870
PubMed 7701499

Eritsland J, Arnesen H, Berg K, Seljeflot I, Abdelnoor M (1995)
Serum Lp(a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n-3 fatty acid supplementation
Scand J Clin Lab Invest, 55 (4), 295-300
DOI 10.3109/00365519509104966, PubMed 7569731

Eritsland J, Arnesen H, Fjeld NB, Grønseth K, Abdelnoor M (1995)
Risk factors for graft occlusion after coronary artery bypass grafting
Scand J Thorac Cardiovasc Surg, 29 (2), 63-9
DOI 10.3109/14017439509107204, PubMed 8643928

Eritsland J, Arnesen H, Seljeflot I, Høstmark AT (1995)
Long-term metabolic effects of n-3 polyunsaturated fatty acids in patients with coronary artery disease
Am J Clin Nutr, 61 (4), 831-6
DOI 10.1093/ajcn/61.4.831, PubMed 7702027

Eritsland J, Arnesen H, Seljeflot I, Kierulf P (1995)
Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease
Blood Coagul Fibrinolysis, 6 (1), 17-22
DOI 10.1097/00001721-199502000-00003, PubMed 7795149

Eritsland J, Gjønnes G, Sandset PM, Seljeflot I, Arnesen H (1995)
Activated protein C resistance and graft occlusion after coronary artery bypass surgery
Thromb Res, 79 (2), 223-6
DOI 10.1016/0049-3848(95)91526-q, PubMed 7676409

Eritsland J, Seljeflot I, Arnesen H, Westvik AB, Kierulf P (1995)
Effect of long-term, moderate-dose supplementation with omega-3 fatty acids on monocyte procoagulant activity and release of interleukin-6 in patients with coronary artery disease
Thromb Res, 77 (4), 337-46
DOI 10.1016/0049-3848(95)93837-p, PubMed 7740525

Publications 1994

Eritsland J, Arnesen H, Seljeflot I, Abdelnoor M, Grønseth K, Berg K, Malinow MR (1994)
Influence of serum lipoprotein(a) and homocyst(e)ine levels on graft patency after coronary artery bypass grafting
Am J Cardiol, 74 (11), 1099-102
DOI 10.1016/0002-9149(94)90459-6, PubMed 7977066

ERITSLAND J, SELJEFLOT I, ABDELNOOR M, ARNESEN H (1994)
LONG-TERM INFLUENCE OF OMEGA-3-FATTY-ACIDS ON FIBRINOLYSIS, FIBRINOGEN, AND SERUM-LIPIDS
Fibrinolysis, 8 (2), 120-125
DOI 10.1016/S0268-9499(05)80029-3

Eritsland J, Seljeflot I, Abdelnoor M, Arnesen H, Torjesen PA (1994)
Long-term effects of n-3 fatty acids on serum lipids and glycaemic control
Scand J Clin Lab Invest, 54 (4), 273-80
DOI 10.3109/00365519409087522, PubMed 7939369

Seljeflot I, Eritsland J, Andersen P, Arnesen H (1994)
Global fibrinolytic capacity assessed by the serum D-dimer test. Correlation between basal and stimulated values
Thromb Res, 75 (2), 157-62
DOI 10.1016/0049-3848(94)90064-7, PubMed 7974389

Seljeflot I, Eritsland J, Torjesen P, Arnesen H (1994)
Insulin and PAI-1 levels during oral glucose tolerance test in patients with coronary heart disease
Scand J Clin Lab Invest, 54 (3), 241-6
DOI 10.3109/00365519409088431, PubMed 8036449

Publications 1993

Landmark K, Thaulow E, Hysing J, Mundal HH, Eritsland J, Hjermann I (1993)
Effects of fish oil, nifedipine and their combination on blood pressure and lipids in primary hypertension
J Hum Hypertens, 7 (1), 25-32
PubMed 8450517

SELJEFLOT I, ARNESEN H, ERITSLAND J, SMITH P (1993)
D-DIMER TEST AFTER STANDARDIZED COAGULATION - A NEW ASSAY FOR GLOBAL EVALUATION OF THE UNSTIMULATED FIBRINOLYTIC SYSTEM
Fibrinolysis, 7 (5), 303-307
DOI 10.1016/0268-9499(93)90145-L

Publications 1992

Eritsland J, Seljeflot I, Arnesen H, Smith P, Westvik AB (1992)
Effects of long-term treatment with warfarin on fibrinogen, FPA, TAT, and D-dimer in patients with coronary artery disease
Thromb Res, 66 (1), 55-60
DOI 10.1016/0049-3848(92)90155-4, PubMed 1412183

Westheim A, Os I, Thaulow E, Kjeldsen SE, Eritsland J, Eide IK (1992)
Haemodynamic and neurohumoral effects of cold pressor test in severe heart failure
Clin Physiol, 12 (1), 95-106
DOI 10.1111/j.1475-097x.1992.tb00296.x, PubMed 1541087

Publications 1989

Eritsland J, Arnesen H, Smith P, Seljeflot I, Dahl K (1989)
Effects of highly concentrated omega-3 polyunsaturated fatty acids and acetylsalicylic acid, alone and combined, on bleeding time and serum lipid profile
J Oslo City Hosp, 39 (8-9), 97-101
PubMed 2809856

Smith P, Arnesen H, Opstad T, Dahl KH, Eritsland J (1989)
Influence of highly concentrated n-3 fatty acids on serum lipids and hemostatic variables in survivors of myocardial infarction receiving either oral anticoagulants or matching placebo
Thromb Res, 53 (5), 467-74
DOI 10.1016/0049-3848(89)90201-6, PubMed 2660319

Publications 1988

Eritsland J, Landmark K (1988)
[Calcium antagonists. Effect on blood platelets and atherosclerosis]
Tidsskr Nor Laegeforen, 108 (10), 736-8
PubMed 3283997

Publications 1983

Eritsland J, Langlo L, Rundén TO, Runde IM (1983)
[Heart contusion after non-penetrating injuries of the torso]
Tidsskr Nor Laegeforen, 103 (25), 1738-40
PubMed 6648904

Publications 1982

Eritsland J, Soldal D (1982)
[Myocardial infarction in young people. Occurrence, risk factors and prognosis]
Tidsskr Nor Laegeforen, 102 (31), 1635-7
PubMed 7167931